RRM2 and hepatocellular carcinoma: RRM2 promotes oncogenic effects in HCC by triggering Wnt/β-catenin signaling, whereas miR-582-3p depletes RRM2 expression, thereby impairing the activation of Wnt/β-catenin signaling and blocking the progression of HCC [82].